Cachar Cancer Hospital Molecular Oncology JRF Vacancy leading to PhD

JRF position leading to PhD in a DBT collaborative project between Tata Memorial Centre, Mumbai and Cachar Cancer Hospital & Research Centre, Silchar (DSIR SIRO) is available for a motivated candidate.  We may facilitate and encourage the selected candidate to register for their PhD in Molecular Oncology.

The selected candidate will work in a DBT Twining project that is in collaboration with Tata Memorial Centre, Mumbai entitled “Assessment of role of Human papilloma virus (HPV) Infection in solid tumors". The candidate will also get the opportunity to work on other ongoing projects.

He/She will get the opportunity to work on the interface of basic and clinical cancer biology. The project is for 2 years duration. We may extend the fellowship support to the selected candidate till his/her PhD completion depending upon their overall performance.

JRF will work at Cachar Cancer Hospital & Research Centre, Silchar, Assam. He/She will have the opportunity to visit collaborating centre's including TMH Mumbai.

JRFINR 25,000/- + 10% HRA (candidates with M. Tech, MBBS, MVsc or NET JRF qualified). For others the fellowship will be 12,000/- + 10% HRA
MSc/MTech in Biological Sciences (Bioinformatics, Biotech,  Life Sciences, Pharmaceuticals, Biochemistry, Genetics, Genomics, etc.), MBBS / MVs
Good academic record with commitment to enroll for a PhD program that will last for 3-4 years.

Potential candidates of all nationalities can apply for this position. We are an equal opportunity provider. We reserve the right to change, modify or terminate the available positions.

Selected candidate will get the opportunity to learn and work with various techniques like Flow Cytometry, qPCR. IHC and NGS besides working with the team of super specialist oncologists.

We may arrange Skype/telephonic interview for outstation shortlisted candidates. 

Interested candidate should email their CV (2 page maximum), and contact reference address to Dr. Rajeev Kumar on  latest by April 22, 2018.

Post a comment